Innovative cancer immunotherapy, anti-PD-1 antibody Nivolumab

被引：0
|
作者：
Shibayama, Shiro [1 ]
机构：
[1] ONO Pharm, Res Cent Immunol, Osaka, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2017年 / 133卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
1-CS-01-1
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [1] Anti-PD-1 monoclonal antibody Cancer immunotherapy
    da Silva, R. Moreira
    [J]. DRUGS OF THE FUTURE, 2014, 39 (01) : 15 - 24
  • [2] Effect of anti-PD-1 antibody, nivolumab on early gastric cancer
    Koji Fukuda
    Taichi Yoshida
    Kazuhiro Shimazu
    Daiki Taguchi
    Masahiro Inoue
    Hiroshi Nanjyo
    Hiroyuki Shibata
    [J]. International Cancer Conference Journal, 2017, 6 (3) : 98 - 103
  • [3] Combination therapy with nivolumab (anti-PD-1 monoclonal antibody): A new era in tumor immunotherapy
    Kiasari, Bahman Abedi
    Abbasi, Arash
    Darestani, Nadia Ghasemi
    Adabi, Nasim
    Moradian, Arsalan
    Yazdani, Yalda
    Hosseini, Golsa Sadat
    Gholami, Nasrin
    Janati, Sheida
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
  • [4] Acute Lymphocytic Myocarditis With Anti-PD-1 Antibody Nivolumab
    Tadokoro, Tomonori
    Keshino, Eri
    Makiyama, Akitaka
    Sasaguri, Takakazu
    Ohshima, Koichi
    Katano, Harutaka
    Mohri, Masahiro
    [J]. CIRCULATION-HEART FAILURE, 2016, 9 (10)
  • [5] Development of novel combination cancer immunotherapy using anti-PD-1 and anti-PD-L1 antibody
    Hasegawa, Hirotaka
    Sugiyama, Daisuke
    Kanda, Mitsuro
    Hayashi, Masamichi
    Tanaka, Chie
    Yamada, Suguru
    Nakayama, Goro
    Koike, Masahiko
    Nomoto, Shuji
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    Nishikawa, Hiroyoshi
    [J]. CANCER SCIENCE, 2021, 112 : 741 - 741
  • [6] A PHASE II CLINICAL TRIAL OF IMMUNOTHERAPY WITH ANTI-PD-1 ANTIBODY (NIVOLUMAB) IN ADVANCED/RELAPSED, PLATINUM-RESISTANT OVARIAN CANCER
    Hamanishi, J.
    Mandai, M.
    Matsumura, N.
    Abiko, K.
    Baba, T.
    Yamaguchi, K.
    Ueda, M.
    Horikawa, N.
    Murakami, R.
    Koshiyama, M.
    Konishi, I.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 400 - 401
  • [7] Successful treatment of refractory Sezary syndrome by anti-PD-1 antibody (nivolumab)
    Kaini Shen
    Yuehua Liu
    Xinxin Cao
    Daobin Zhou
    Jian Li
    [J]. Annals of Hematology, 2017, 96 : 687 - 688
  • [8] Successful treatment of refractory Sezary syndrome by anti-PD-1 antibody (nivolumab)
    Shen, Kaini
    Liu, Yuehua
    Cao, Xinxin
    Zhou, Daobin
    Li, Jian
    [J]. ANNALS OF HEMATOLOGY, 2017, 96 (04) : 687 - 688
  • [9] Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma
    Fu, Yuyin
    Peng, Yujia
    Zhao, Shengyan
    Mou, Jun
    Zeng, Lishi
    Jiang, Xiaohua
    Yang, Chengli
    Huang, Cheng
    Li, Yuyan
    Lu, Yin
    Wu, Mengdan
    Yang, Yanfang
    Kong, Ting
    Lai, Qinhuai
    Wu, Yangping
    Yao, Yuqin
    Wang, Yuxi
    Gou, Lantu
    Yang, Jinliang
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [10] Systemic treatment with anti-PD-1 antibody nivolumab in combination with vaccine therapy in advanced pancreatic cancer
    Nesselhut, Jan
    Marx, Dagmar
    Lange, Hans
    Regalo, Goncalo
    Cillien, Nicole
    Chang, Raymond Y.
    Nesselhut, Thomas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345